Hypertriglyceridemia: Apheretic treatment

International Journal of Artificial Organs

Volumn 28, Issue 10, 2005, Pages 1018-1024

  Giannini, Gabriella ^a   Valbonesi, M ^a   Morelli, F ^a   Carlier, P ^a   De Luigi, M C ^a   Dejana, A M ^a   Ruzzenenti, M R ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Cascade filtration; Double filtration; Hypertriglyceridemia; Plasmapheresis

Indexed keywords

PATIENT MONITORING; PATIENT TREATMENT;

ACUTE PANCREATITIS; BONE MARROW TRANSPLANTATION; CASCADE FILTRATION; CYCLOSPORIN A; DOUBLE FILTRATION; HYPERTRIGLYCERIDEMIA; PLASMAPHERESIS; REMOVAL RATE; TRIGLYCERIDE LEVELS; TRIGLYCERIDE-RICH LIPOPROTEINS;

VEGETABLE OILS;

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CYCLOSPORIN A; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ACUTE PANCREATITIS; ARTICLE; BONE MARROW TRANSPLANTATION; FILTER; GRAFT REJECTION; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INTERMETHOD COMPARISON; PLASMAPHERESIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 29244457543     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502801009     Document Type: Article

References (27)

1. Sanfey H, Cameron JL. Pancreatitis and hyperlipemia. In: Berk JE, ed. Gastroenterology, 4th ed. Philadelphia: Saunders; 1985. p 4055-71.
2. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330: 1198-210.
3. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Metabolic basis of inherited disease, 6th ed. New York: McGraw-Hill; 1989. p 1165-80.
4. Larsen ML, Illingworth DR. Triglyceride-lowering agents: Fibrates and nicotinic acid. Curr Opin Lipidol 1993; 4: 34-40.
5. Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern Med 1992; 37: 249-73.
6. Nilsson-Ehle P. Lipolytic enzymes and plasma lipoprotein metabolism. Annu Rev Biochem 1980; 49: 667-93.
7. Grundy SM, Mok HY, Zech L, et al. Transport of very low density lipoprotein-triglycerides in varying grades of obesity and hypertriglyceridemia. J Clin Invest 1979; 63: 1274-83.
8. Thompson GR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolemia. Lancet 1975; 1: 1208-11.
9. Thompson GR, Miller JP, Breslow JL. Improved survival of patients with homozygous familial hypercholesterolemia treated with plasma exchange. Br Med J 1985; 291: 1671-3.
10. Homma Y, Mikami J, Tamachi H, et al. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis. Atherosclerosis 1986; 60: 23-7.
11. Mabuchi H, Sakai T, Sakai Y, et al. Treatment of homozygous patients with familial hypercholesterolemia by double-filtration plasmapheresis. Atherosclerosis 1986; 61: 135-40.
12. Lupien PJ, Moorjani S, Awad J. A new approach in the management of familial hypercholesterolemia removal of plasma-cholesterol based on the principle of affinity chromatografy. Lancet 1976; 1: 1261-5.
13. Graisley B, Cloarec M, Salmon S, et al. Extracorporeal plasma therapy for homozygous familial hypercholesterolemia. Lancet 1980; 2: 1147.
14. Stoffel W, Boberg H, Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia. Lancet 1981; 2: 1005-7.
15. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985; 5: 613-22.
16. Betteridge DJ, Bakowsky M, Taylor KG, et al. Treatment of severe diabetic hypertriglyceridemia by plasma exchange. Lancet 1978; 1: 1368.
17. Ito H, Naito C, Hayashi H, et al. Selective removal of triglyceride-rich lipoproteins by plasmapheresis in diabetic patients with severe hypertriglyceridemia. Artif Organs 1989; 13: 190-6.
18. Lennertz A, Parhofer KG, Samtleben W, Bosch T. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther Apher 1999; 3: 227-33.
19. Coman T, Dalloz MA, Coolen N, et al. Plasmapheresis for the treatment of acute pancreatitis induced by hemophagocytic syndrome related to hypertriglyceridemia. J Clin Apher 2003; 18: 129-31.
20. Sakuma N, Iwata S, Ikeuchi R, et al. Coexisting type III hyperlipoproteinemia and familial hypercholesterolemia: A case report. Metabolism 1995; 44: 460-5.
21. Soler NG, Wortsman J, Chopra IJ. Lipoatrophic diabetes: endocrine dysfunction and the response to control of hypertriglyceridemia. Metabolism 1982; 31: 19-24.
22. Routy JP, Smith G, Blank DW, Gilfix BM. Plasmapheresis in the treatment of an acute pancreatitis due to protease inhibitor-induced hypertriglyceridemia. J Clin Apher 2001; 16: 157-9.
23. Periard D, Telenti A, Sudre P, et al. Atherogenic dyslipidemia in HIV-Infected individuals treated with protease inhibitors: The Swiss HIV Cohort Study. Circulation 1999; 100: 700-5.
24. Perry RC, Cushig HE, Deeg MA, Prince MJ. Ritonavir, triglycerides and pancreatitis. Clin Infect Dis 1999; 28: 161-2.
25. Yeh JH, Lee MF, Chiu HC. Plasmapheresis for severe lipemia comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants. J Clin Apher 2003; 18: 32-6.
26. Sgouts D, MacMahon W, Love A, Jerkunica I. Interaction of cyclosporin A with the human lipoproteins. J Pharm Pharmacol 1986; 38: 583-8.
27. Harris KPG, Russel GI, Parvin SD, et al. Alteration in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br Med J 1986; 292: 16-7.